Drug Resistance Effect on Metastasis by Activating EMT Pathway in Meningioma

2023-1-16
Karakaya, İdil Gül
Show full item record
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
103
views
8
downloads
Cancer is one of the leading and often fatal diseases in humans. Cancerous cells can arise within any tissue or organ in the body. Treatment of cancer includes but is not limited to radiotherapy, chemotherapy, immunotherapy, or targeted therapy options. Meningioma, one of the brain malignancies, is the subject of this research. As it is known, cancer cells can spread to other organs and this is called metastasis. Different biological pathways contribute to the migration of cells. Epithelial to mesenchymal transition (EMT) is the pathway that primarily affects cancer metastasis. Certain EMT indicators and transcription factors are differentially regulated as the EMT pathway is activated. E-cadherin, N-cadherin, Vimentin, and β–Catenin are important EMT indicators. In our study, CDH1 expression is lower in a benign meningioma cell line, AC599, compared to a malignant meningioma cell line, IOMM Lee. It is well known that CDH2 and VIM expressions increase, while CDH1 expressions decrease during EMT. This increment of VIM and CDH2 has been seen in the AC599 meningioma cell line upon gaining JQ1 drug resistance (AC599 JR). We observed that the expression of SNAIL, SLUG, and TWIST is increased in the vi JQ1 Resistant AC599 cell line (AC599 JR) more than in the JQ1 Resistant IOMM Lee (IOMM Lee JR) cell line. Chemoresistance is a major obstacle in cancer therapy and could be caused by various factors and pathways, among which the EMT mechanism has recently received attention for its role in drug resistance in addition to metastasis. EMT contributes to drug resistance in many cancer types, especially pancreatic, bladder, and breast cancer. Overall, our study indicates that JQ1 drug resistance increases migration and mesenchymal properties of AC599, benign meningioma cell line more than IOMM Lee, malignant meningioma cell line. RNAseq data indicates that STAT family transcription factors play a major role in JQ1 chemoresistant meningioma cell lines. STAT3 inhibition by using Stattic reduces meningioma cell proliferation and migration, and in some cases stops cell migration. This observation is specific to the NF2 mutation status of meningioma. NF2 protein is known to play a role in EMT activation and NF2 loss is very common in meningioma which is associated with the downregulation of CDH1 in meningioma. In conclusion, JQ1 and Stattic drug treatments are viable therapy options for meningioma chemotherapy. Furthermore, our results suggest the importance of cell and pathway-specific approaches for effective cancer treatment.
JQ1, Meningioma, EMT pathway, Drug resistance, Bromodomain inhibitor
https://hdl.handle.net/11511/102111
Graduate School of Natural and Applied Sciences, Thesis

Suggestions

PEI – starch nanoparticles for cancer gene therapy
Kandemir, Berke Bilgenur; Hasırcı, Vasıf Nejat; Aşçıoğlu Öz, Gamze; Department of Biotechnology (2013)
Cancer is the most serious disease of in this century and death rates due cancer are increasing rapidly. Since the conventional cancer treatment techniques like chemotherapy, radiation therapy and surgical operations are not sufficiently efficient and they even are harmful for healthy tissues, there is an urgent need for effective treatment techniques with minimal or no side effects. Controlled drug delivery systems are offered as an alternative approach to cancer therapy that helps prevent excessive drug u...
Identification of gene mutations involved in drug resistance in liver cancer using RNA-SEQ data analysis
Shojaei, Mona; Atalay, Rengül; Acar, Aybar Can; Department of Bioinformatics (2016)
A significant concern in cancer research is the detection of cancer associated somatic mutations. Liver cancer is the 5th most common and 2nd deadliest cancer in the world. Several somatic mutations were previously reported in liver cancer but their relations to chemotherapeutic response was not studied in detail. In this study, the relationship between mutation status and drug treatment response of well-differentiated Huh7 and poorly-differentiated Mahlavu liver cancer cells were analyzed. The RNA-Seq data...
Investigation of Effects of Microenvironment and Immune Cells onTumor Growth by Agent Based Modeling
Orta Doğu Teknik Üniversitesi, Deniz Bilimleri Enstitüsü (Orta Doğu Teknik Üniversitesi Enformatik Enstitüsü; 2022-10)
Cancer is one of the diseases that humanity suffered for a long time. We understand many aspects of this disease, but there is still much to learn. Because it is a complex disease that affects many processes, organs, cell types, and so on. We need to investigate cellular components, interactions and processes that are related to cancer as a whole to understand its structure. In this scope, investigating the microenvironment of tumors and interactions in it can reveal fundamental features of cancer. One of t...
Structural mapping and network analysis of patient-specific mutations in glioblastoma
Kaya, Tuğba; Tunçbağ, Nurcan; Doğan, Tunca; Department of Bioinformatics (2018)
Cancer is one of the most common cause of death worldwide. It occurs as a result of a collection of somatic deviations from normal state. Therefore, many efforts have been invested to profile mutations in different types of tumors; such as, the Cancer Genome Atlas (TCGA) which deposits multiple omic data for more than 11,000 tumor samples. In this thesis, we present a pipeline which retrieves patient-specific mutation data in Glioblastoma from TCGA, maps these mutations on the protein structures in Protein ...
Contribution of different types of -omic data on personalized diagnosis of cancer
Tanıl, Ezgi; Kızılilsoley, Nehir; Nikerel, Emrah (Orta Doğu Teknik Üniversitesi Enformatik Enstitüsü; 2022-10)
Cancer is a complex disease which is one of the main causes of death globally. Survival rate of cancer increases if early diagnosis and application of appropriate treatment are available [1,2]. Understanding differential response from one patient to another can aid in drug targeting, understanding disease progression and finding efficient treatment strategies. Tumour cells shown to have altered metabolism and the most commonly defined example is the Warburg effect in which tumour cells shown to use lactic a...
Citation Formats
İ. G. Karakaya, “Drug Resistance Effect on Metastasis by Activating EMT Pathway in Meningioma,” M.S. - Master of Science, Middle East Technical University, 2023.
METU IIS - Integrated Information Service open@metu.edu.tr